Advertisement

American Journal of Cardiovascular Drugs

, Volume 12, Issue 2, pp 105–116 | Cite as

Calcium Intake and Risk of Cardiovascular Disease

A Review of Prospective Studies and Randomized Clinical Trials
Review Article

Abstract

The potential effects of inadequate or excessive calcium supply on cardiovascular disease (CVD) are receiving growing attention. We review experimental, epidemiologic, and clinical evidence regarding the role of calcium intake in the development of CVD in adults. In vitro and in vivo laboratory studies have shown that calcium may affect the risk of developing CVD through multiple mechanisms including blood cholesterol, insulin secretion and sensitivity, vasodilation, inflammatory profile, thrombosis, obesity, and vascular calcification. A number of prospective epidemiologic studies have examined the relationship between dietary calcium intake and CVD incidence or mortality in middle-aged and older adults. The results were inconsistent, and the pooled data do not strongly support a significant effect of greater dietary calcium intake on the risk of coronary artery disease (CAD) or stroke. Only a few prospective studies have examined calcium supplement use in association with risk of CVD. The pooled data show no significant benefits of calcium supplement use in reducing the risk of CAD or stroke. No randomized clinical trial has specifically tested the effect of calcium supplementation on CVD as its primary endpoint. Secondary analyses in existing trials to date suggest a neutral effect of calcium (with or without vitamin D) supplements on CVD events, but do not allow for a definitive conclusion. A large percentage of Americans, particularly older adults, fail to meet the US recommendations for optimal calcium intake and are encouraged to increase daily calcium consumption. More prospective cohort studies and large-scale randomized trials are needed to further evaluate the risks or benefits of calcium supplementation on CVD endpoints as the primary pre-specified outcome.

Keywords

Calcium Intake Calcium Supplement Dietary Calcium Dietary Calcium Intake Pool Relative Risk 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The authors are grateful for the technical assistance from Dr Yiqing Song in his scientific input into the meta-analysis. Dr Wang was supported by a career development grant HL095649 from the National Institutes of Health, Bethesda, MD, USA. The authors have no conflicts of interest that are directly relevant to the content of this review.

References

  1. 1.
    Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 2005 May; 35 (5): 290–304.PubMedCrossRefGoogle Scholar
  2. 2.
    Subar AF, Block G. Use of vitamin and mineral supplements: demographics and amounts of nutrients consumed. The 1987 Health Interview Survey. Am J Epidemiol 1990 Dec; 132 (6): 1091–101.PubMedGoogle Scholar
  3. 3.
    Riffenburgh RH (editor). Statistics in medicine. 2nd ed. Waltham (MA): Academic Press, 2005.Google Scholar
  4. 4.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7 (3): 177–88.PubMedCrossRefGoogle Scholar
  5. 5.
    Vaskonen T. Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem 2003 Sep; 14 (9): 492–506.PubMedCrossRefGoogle Scholar
  6. 6.
    Heaney RP. Calcium intake and disease prevention. Arq Bras Endocrinol Metabol 2006; 50 (4): 685–93.PubMedCrossRefGoogle Scholar
  7. 7.
    Mundy GR, Guise TA. Hormonal control of calcium homeostasis. Clin Chem 1999; 45 (8 Pt2): 1347–52.PubMedGoogle Scholar
  8. 8.
    Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy Press; 2011.Google Scholar
  9. 9.
    NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. JAMA 1994 Dec 28; 272 (24): 1942–8.CrossRefGoogle Scholar
  10. 10.
    Bennett T, Desmond A, Harrington M, et al. The effect of high intakes of casein and casein phosphopeptide on calcium absorption in the rat. Br J Nutr 2000 Jun; 83 (6): 673–80.PubMedCrossRefGoogle Scholar
  11. 11.
    Fleischman AI, Yacowitz H, Hayton T, et al. Effects of dietary calcium upon lipid metabolism in mature male rats fed beef tallow. J Nutr 1966 Mar; 88 (3): 255–60.PubMedGoogle Scholar
  12. 12.
    Yacowitz H, Fleischman AI, Bierenbaum ML, et al. Calcium and lipid metabolism: effects of increased dietary calcium on atherosclerosis in rabbits. Trans N Y Acad Sci 1971 Mar; 33 (3): 344–50.PubMedCrossRefGoogle Scholar
  13. 13.
    Resnick LM, Laragh JH, Sealey JE, et al. Divalent cations in essential hypertension: relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med 1983 Oct 13; 309 (15): 888–91.PubMedCrossRefGoogle Scholar
  14. 14.
    Resnick LM. The role of dietary calcium in hypertension: a hierarchical overview. Am J Hypertens 1999 Jan; 12 (1 Pt 1): 99–112.PubMedCrossRefGoogle Scholar
  15. 15.
    Bohr DF. Vascular smooth muscle: dual effect of calcium. Science 1963 Feb 15; 139 (3555): 597–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Zemel MB. Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 2001 Oct; 20 (5 Suppl.): 428S–35S; discussion 40S-42S.PubMedGoogle Scholar
  17. 17.
    Draznin B. Intracellular calcium, insulin secretion, and action. Am J Med 1988 Nov 28; 85 (5A): 44–58.PubMedCrossRefGoogle Scholar
  18. 18.
    Williams PF, Caterson ID, Cooney GJ, et al. High affinity insulin binding and insulin receptor-effector coupling: modulation by Ca2+. Cell Calcium 1990 Sep; 11 (8): 547–56.PubMedCrossRefGoogle Scholar
  19. 19.
    Draznin B, Sussman K, Kao M, et al. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem 1987 Oct 25; 262 (30): 14385–8.PubMedGoogle Scholar
  20. 20.
    Zemel MB. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem 1998 Nov; 188 (1–2): 129–36.PubMedCrossRefGoogle Scholar
  21. 21.
    Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2007 Jun; 92 (6): 2017–29.PubMedCrossRefGoogle Scholar
  22. 22.
    Renaud S, Ciavatti M, Thevenon C, et al. Protective effects of dietary calcium and magnesium on platelet function and atherosclerosis in rabbits fed saturated fat. Atherosclerosis 1983 May; 47 (2): 187–98.PubMedCrossRefGoogle Scholar
  23. 23.
    Makynen H, Kahonen M, Wu X, et al. Endothelial function in deoxycorticosterone-NaCl hypertension: effect of calcium supplementation. Circulation 1996 Mar 1; 93 (5): 1000–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Tolvanen JP, Makynen H, Wu X, et al. Effects of calcium and potassium supplements on arterial tone in vitro in spontaneously hypertensive rats. Br J Pharmacol 1998 May; 124 (1): 119–28.PubMedCrossRefGoogle Scholar
  25. 25.
    Jolma P, Kalliovalkama J, Tolvanen JP, et al. High-calcium diet enhances vasorelaxation in nitric oxide-deficient hypertension. Am J Physiol Heart Circ Physiol 2000 Sep; 279 (3): H 1036–43.Google Scholar
  26. 26.
    Seely S. Is calcium excess in western diet a major cause of arterial disease. Int J Cardiol 1991 Nov; 33 (2): 191–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Ojuka EO. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc 2004 May; 63 (2): 275–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Wright DC, Hucker KA, Holloszy JO, et al. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 2004 Feb; 53 (2): 330–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Van der Vijver LP, van der Waal MA, Weterings KG, et al. Calcium intake and 28-year cardiovascular and coronary heart disease mortality in Dutch civil servants. Int J Epidemiol 1992 Feb; 21 (1): 36–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Abbott RD, Curb JD, Rodriguez BL, et al. Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program. Stroke 1996 May; 27 (5): 813–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 1998 Sep 22; 98 (12): 1198–204.PubMedCrossRefGoogle Scholar
  32. 32.
    Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999 Jan 15; 149 (2): 151–61.PubMedCrossRefGoogle Scholar
  33. 33.
    Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 1999 Sep; 30 (9): 1772–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Al-Delaimy WK, Rimm E, Willett WC, et al. A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. Am J Clin Nutr 2003 Apr; 77 (4): 814–8.PubMedGoogle Scholar
  35. 35.
    Marniemi J, Alanen E, Impivaara O, et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 2005 Jun; 15 (3): 188–97.PubMedCrossRefGoogle Scholar
  36. 36.
    Umesawa M, Iso H, Date C, et al. Dietary intake of calcium in relation to mortality from cardiovascular disease: the JACC Study. Stroke 2006 Jan; 37 (1): 20–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Larsson SC, Virtanen MJ, Mars M, et al. Magnesium, calcium, potassium, and sodium intakes and risk of stroke in male smokers. Arch Intern Med 2008 Mar 10; 168 (5): 459–65.PubMedCrossRefGoogle Scholar
  38. 38.
    Umesawa M, Iso H, Ishihara J, et al. Dietary calcium intake and risks of stroke, its subtypes, and coronary heart disease in Japanese: the JPHC Study Cohort I. Stroke 2008 Sep; 39 (9): 2449–56.PubMedCrossRefGoogle Scholar
  39. 39.
    Kaluza J, Orsini N, Levitan EB, et al. Dietary calcium and magnesium intake and mortality: a prospective study of men. Am J Epidemiol 2010 Apr 1; 171 (7): 801–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Pentti K, Tuppurainen MT, Honkanen R, et al. Use of calcium supplements and the risk of coronary heart disease in 52–62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas 2009 May 20; 63 (1): 73–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Lind L, Skarfors E, Berglund L, et al. Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 1997 Aug; 50 (8): 967–73.PubMedCrossRefGoogle Scholar
  42. 42.
    Foley RN, Collins AJ, Ishani A, et al. Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008 Sep; 156 (3): 556–63.PubMedCrossRefGoogle Scholar
  43. 43.
    Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999 Jan 14; 340 (2): 101–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Prince RL, Devine A, Dhaliwal SS, et al. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 2006 Apr 24; 166 (8): 869–75.PubMedCrossRefGoogle Scholar
  45. 45.
    Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008 Feb 2; 336 (7638): 262–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Reid IR, Ames R, Mason B, et al. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 2008 Nov 10; 168 (20): 2276–82.PubMedCrossRefGoogle Scholar
  47. 47.
    Brazier M, Grados F, Kamel S, et al. Clinical and laboratory safety of one year’s use of a combination calcium+vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2005 Dec; 27 (12): 1885–93.PubMedCrossRefGoogle Scholar
  48. 48.
    Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007 Feb 20; 115 (7): 846–54.PubMedCrossRefGoogle Scholar
  49. 49.
    Lappe JM, Heaney RP. Calcium supplementation: results may not be generalisable [letter]. BMJ 2008 Feb 23; 336 (7641): 403; author reply 4.CrossRefGoogle Scholar
  50. 50.
    Lewis JR, Calver J, Zhu K, et al. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res 2011; 26 (1): 35–41.PubMedCrossRefGoogle Scholar
  51. 51.
    McCarron DA, Reusser ME. Finding consensus in the dietary calcium-blood pressure debate. J Am Coll Nutr 1999 Oct; 18 (5 Suppl.): 398S–405S.PubMedGoogle Scholar
  52. 52.
    Reid IR, Bolland MJ. Calcium supplementation and vascular disease. Climacteric 2008 Aug; 11 (4): 280–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Reid IR, Schooler BA, Hannan SF, et al. The acute biochemical effects of four proprietary calcium preparations. Aust N Z J Med 1986 Apr; 16 (2): 193–7.PubMedCrossRefGoogle Scholar
  54. 54.
    Green JH, Booth C, Bunning R. Postprandial metabolic responses to milk enriched with milk calcium are different from responses to milk enriched with calcium carbonate. Asia Pac J Clin Nutr 2003; 12 (1): 109–19.PubMedGoogle Scholar
  55. 55.
    Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010; 341: c3691. doi:10.1136/bmj.c3691.PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2012

Authors and Affiliations

  • Lu Wang
    • 1
  • JoAnn E. Manson
    • 1
    • 2
  • Howard D. Sesso
    • 1
    • 2
    • 3
  1. 1.Division of Preventive Medicine, Department of MedicineBrigham and Women’s HospitalBostonUSA
  2. 2.Department of EpidemiologyHarvard School of Public HealthBostonUSA
  3. 3.Division of Aging, Department of MedicineBrigham and Women’s HospitalBostonUSA

Personalised recommendations